Literature DB >> 25744711

Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts?

Orhan Bozoglan1, Bulent Mese2, Erdinc Eroglu2, Serdal Elveren2, Mustafa Gul3, Ahmet Celik4, Halil Ibrahim Yildirimdemir2, Harun Ciralik5, Alptekin Yasim2.   

Abstract

PURPOSE: The aim of this study was to determine whether polytetrafluoroethylene grafts or Omniflow II biosynthetic grafts are more resistant to infection caused by Staphylococcus aureus.
METHODS: Sixty rats were divided into six groups. In Groups 1A, 1B and 1C, a polytetrafluoroethylene graft was implanted in each rat, and, in Groups 2A, 2B and 2C, a biosynthetic graft was implanted in each rat. Staphylococcus aureus was inoculated into Groups 1B, 1C, 2B and 2C, and the rats in Groups 1C and 2C were treated with teicoplanin. One week later, the rats were euthanized, the grafts were removed and a microbiological count was performed. A histopathological examination was subsequently carried out, and the C-reactive protein, prealbumin and leukocyte levels were investigated.
RESULTS: There were no significant differences in the C-reactive protein, prealbumin and leukocyte levels. The differences in the results of the microbiological evaluations between the groups were significant. The quantitative culture results showed no bacterial growth in Groups 1A, 1C and 2A. The number of bacteria in Group 1B was statistically lower than that in Group 2B. When the groups receiving treatment were compared, Group 2C had bacterial growth, whereas Group 1C did not. The histopathological examinations showed similar results.
CONCLUSIONS: Omniflow II grafts are more susceptible to infection than polytetrafluoroethylene grafts.

Entities:  

Keywords:  Graft infection; Omniflow II; PTFE graft

Mesh:

Substances:

Year:  2015        PMID: 25744711     DOI: 10.1007/s00595-015-1141-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  15 in total

1.  Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture.

Authors:  A Giacometti; O Cirioni; M S Del Prete; F Barchiesi; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.

Authors:  A Yasim; M Gul; H Ciralik; Y Ergun
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-05-24       Impact factor: 7.069

3.  Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.

Authors:  A Yasim; M Gul; E Atahan; P Ciragil; M Aral; Y Ergun
Journal:  Eur J Vasc Endovasc Surg       Date:  2005-12-15       Impact factor: 7.069

4.  [Femoropopliteal vascular replacement: vein, ePTFE or ovine collagen?].

Authors:  G Koch; S Gutschi; O Pascher; J Fruhwirth; H Hauser
Journal:  Zentralbl Chir       Date:  1996       Impact factor: 0.942

5.  Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal.

Authors:  J M Seeger; H A Pretus; M B Welborn; C K Ozaki; T C Flynn; T S Huber
Journal:  J Vasc Surg       Date:  2000-09       Impact factor: 4.268

Review 6.  [Arterial allografts in vascular surgery--best choice in cases of aortic graft infection?!].

Authors:  P T Fellmer; I Matia; S Jonas
Journal:  Zentralbl Chir       Date:  2013-07-03       Impact factor: 0.942

Review 7.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

8.  Long-term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis.

Authors:  Roberto Palumbo; Pasquale Niscola; Santo Calabria; Sabrina Fierimonte; Monica Bevilacqua; Laura Scaramucci; Barbara Tolu; Paolo de Fabritiis; Francesco Bondanini
Journal:  Nephron Clin Pract       Date:  2009-07-14

9.  Treatment strategies for aortic and peripheral prosthetic graft infection.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahiro Toyofuku; Masatoshi Jibiki; Norihide Sugano; Yoshinori Inoue
Journal:  Surg Today       Date:  2013-04-05       Impact factor: 2.549

10.  Use of biosynthetic prosthesis (Omniflow II®) to replace infected infrainguinal prosthetic grafts--first results.

Authors:  Ingolf Töpel; Thomas Betz; Christian Uhl; Matthias Wiesner; Stefan Bröckner; Markus Steinbauer
Journal:  Vasa       Date:  2012-05       Impact factor: 1.961

View more
  3 in total

1.  The impact of inflow treatment for claudicants with both aortoiliac and femoropopliteal occlusive disease.

Authors:  Takashi Maekawa; Kimihiro Komori; Akio Kodama; Hiroshi Banno; Hiroshi Narita; Masayuki Sugimoto
Journal:  Surg Today       Date:  2016-09-01       Impact factor: 2.549

2.  Aortic treatment of native infection by reconstruction with the Omniflow II biologic prosthesis.

Authors:  Majid Harmouche; Frederic Loreille; Florent Le Bars; Etienne Marchand; Michel Aupart; Robert Martinez
Journal:  J Vasc Surg Cases Innov Tech       Date:  2018-12-04

3.  The antibacterial effect of mesenchymThe antibacterial effect of mesenchymal stem cells on graft infections: An experimental studyal stem cells on graft infections: An experimental study.

Authors:  Mehmet Kabalcı; İbrahim Deniz Canbeyli; Erdinç Eroğlu
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.